Notice bibliographique
Résumé
References Äblad B, Bjurö T, Björkman JA et al (1991) Role of central nervous beta-adrenoceptors in the prevention of ventricular fibrillation through augmentation of cardiac vagal tone. J Am Coll Cardiol 17(Suppl):165 CrossRef Google Scholar Abraham J, Mudd JO, Kaput NK et al (2009) Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol 53:1320–1325 CAS PubMed CrossRef Google Scholar Anderson JL, Adams CD, Antman EM et al (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50:e1–e157 PubMed CrossRef Google Scholar ASSENT-4: PCI: Assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention investigators (2006) Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomized trial. Lancet 367:569–578 CrossRef CAS Google Scholar Bangalore S, Messerli F, Kostis J et al (2007) Cardiovascular protection using beta-blockers. A critical review of the evidence. J Am Coll Cardiol 50:563–572 CAS PubMed CrossRef Google Scholar Bøtker HE, Kharbanda R, Schmidt MR et al (2010) Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375:727–734 PubMed CrossRef Google Scholar Bybee KA, Kara T, Prasad A et al (2004) Transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med 141:858 PubMed Google Scholar Bybee KA, Motiei A, Syed IS et al (2007) Electrocardiography cannot reliably differentiate transient left ventricular apical ballooning syndrome from anterior ST-segment elevation myocardial infarction. J Electrocardiol 40:38.e1–38.e6 CrossRef Google Scholar Bybee KA, Prasad A (2008) Stress-related cardiomyopathy syndromes. Circulation 118(4):397–409 PubMed CrossRef Google Scholar Cairns JA, Gent M, Singer J et al (1986) Aspirin, sulfinpyrazone or both in unstable angina. N Engl J Med 313:1369 CrossRef Google Scholar Casscells W, Naghavi M, Willerson JT (2003) Vulnerable atherosclerotic plaque: a multifocal disease. Circulation 107:2072–2075 PubMed CrossRef Google Scholar Collins R, Peto R, Baigent C et al (1997) Aspirin, heparin and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med 336:847 CAS PubMed CrossRef Google Scholar Curtis JP, Portnay EL, Wang Y et al (2006) The pre-hospital electrocardiogram and time to reperfusion in patients with acute myocardial infarction, 2000–2002: findings from the National Registry of Myocardial Infarction-4. J Am Coll Cardiol 47:1544–1552 PubMed CrossRef Google Scholar Denktas AE, Athar H, Henry TD et al (2008) Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone: results of the AMICO (Alliance for Myocardial Infarction Care Optimization) registry. J Am Coll Cardiol Intv 1:504–510 Google Scholar DeWood MA, Spores J, Notske R et al (1980) Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303:897 CAS PubMed CrossRef Google Scholar Dokainish H, Pillai M, Murphy SA et al (2005) Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy. J Am Coll Cardiol 45:19–24 CAS PubMed CrossRef Google Scholar Eagle KA, Goodman SG, Avezum A et al (2002) Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 359:373–377 PubMed CrossRef Google Scholar Eagle KA, Ginsburg GS, Musunuru K et al (2010) Identifying Patients at High Risk of a Cardiovascular Event in the Near Future: Current Status and Future Directions: Report of a National Heart, Lung, and Blood Institute Working Group. Circulation 121:1447–1454 PubMed CrossRef Google Scholar Falk E, Shah PK, Fuster V (1995) Coronary plaque disruption. Circulation 92:657–671 CAS PubMed Google Scholar Fox KA, Steg PG, Eagle KA et al (2007) Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006. JAMA 297:1892–1900 CAS PubMed CrossRef Google Scholar Fox KAA, Clayton TC, Damman P et al for the FIR Collaboration (2010) Long-term outcome of a routine versus selective invasive strategy in patients with Non–ST-segment elevation acute coronary syndrome. A meta-analysis of individual patient data. J Am Coll Cardiol 55:2435–2445 PubMed CrossRef Google Scholar Francone M, Bucciarelli-Ducci C, Carbone I et al (2009) Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with st-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol 54:2145–2153 PubMed CrossRef Google Scholar Gianni M, Dentali F, Grandi AM et al (2006) Apical ballooning syndrome or Takotsubo cardiomyopathy: a systematic review. Eur Heart J 27(13):1523–1529 PubMed CrossRef Google Scholar Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO-III) Investigators (1997) A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 337:1118 CrossRef Google Scholar Gruppo Italiano per lo Studio della Streptochinasi Nell ‘Infarto Miocardico (GISSI) (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1:397, GISSI-1 Google Scholar Gruppo Italiano per lo Studio della Sopravvivenza Nell ‘Infarto Miocardico (1990) A factorial randomised trial of alteplase versus SK and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 336:65. GISSI-2 Google Scholar Horan LG, Flowers NC, Tolleson WJ (1970) The significance of diagnostic Q waves in the presence of bundle branch block. Chest 58:214 CAS PubMed CrossRef Google Scholar International Joint Efficacy Comparison of Thrombolytics (1995) Randomized, double blind comparison of reteplase-double bolus administration with streptokinase in acute myocardial infarction (INJECT): Trial to investigate equivalence. Lancet 46:329. INJECT Google Scholar Keeley EC, Boura JA, Grines CL, ASSENT-4: PCI: Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention investigators (2006) Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomized trial. Lancet 367:569–578 CrossRef CAS Google Scholar Keller T, Zeller T, Peetz D et al (2009) Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 361:868–877 CAS PubMed CrossRef Google Scholar Khan M Gabriel (2005) Acute myocardial infarction. In: Heart disease diagnosis and therapy, 2nd edn. Humana Press, Totowa, p 38 Google Scholar Khan M Gabriel (2006) On call cardiology, 3rd edn. WB Saunders/Elsevier Science, Philadelphia Google Scholar Khan M Gabriel (2007) Beta blocker controversies. In: Cardiac Drug Therapy. Humana Press, Totowa, p 38 Google Scholar Khan M Gabriel (2008) Rapid ECG interpretation. Humana Press, New York CrossRef Google Scholar Khan M Gabriel, Topol EJ (1996) Acute myocardial infarction. In: Heart disease diagnosis and therapy. Williams & Wilkins, Baltimore, p 30 Google Scholar Kosuge M, Ebina T, Hibi K et al (2010) Simple and accurate electrocardiographic criteria to differentiate Takotsubo cardiomyopathy from anterior acute myocardial infarction. J Am Coll Cardiol 55:2514–2516 PubMed CrossRef Google Scholar Kurowski V, Kaiser A, von Hof K et al (2007) Apical and midventricular transient left ventricular dysfunction syndrome (Takotsubo cardiomyopathy) frequency, mechanisms, and prognosis. Chest 132(3):809–816 PubMed CrossRef Google Scholar Lewis HD, Davis JW, Archibald DG et al (1983) Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study. N Engl J Med 309:396 PubMed CrossRef Google Scholar Libby P (2001) Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104:365–372 CAS PubMed Google Scholar Marriott HJL (1988) Practical electrocardiography, 8th edn. Williams & Wilkins, Baltimore, p 469 Google Scholar Martinez MW, Babuin L, Syed IS et al (2007) Myocardial infarction with normal coronary arteries: a role for MRI? Clin Chem 53:995–996 CAS PubMed CrossRef Google Scholar McNamara RL, Herrin J, Bradley EH et al (2006) Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002. J Am Coll Cardiol 47:45–51 PubMed CrossRef Google Scholar Morrow DA (2009) Clinical application of sensitive troponin assays. N Engl J Med 361:913–915 CAS PubMed CrossRef Google Scholar Morrow DA, Cannon CP, Rifai N et al (2001) Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 286:2405–2412 CAS PubMed CrossRef Google Scholar Nallamothu BK, Bates ER (2003) Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol 92:824–826 PubMed CrossRef Google Scholar Nallamothu BK, Bates ER, Wang Y et al (2006) Driving times and distances to hospitals with percutaneous coronary intervention in the United States: implications for prehospital triage of patients with ST-elevation myocardial infarction. Circulation 113:1189–1195 PubMed CrossRef Google Scholar Peters RW, Muller JE, Goldstein S et al for the BHAT Study Group (1989). Propranolol and the morning increase in the frequency of sudden cardiac deaths (BHAT Study). Am J Cardiol 63:1518 CAS PubMed CrossRef Google Scholar Pinto DS, Kirtane AJ, Nallamothu BK et al (2006) Hospitals delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation 114:2019–2025 PubMed CrossRef Google Scholar Reichlin T, Hochholzer W, Bassetti S et al (2009) Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 361:858–867 CAS PubMed CrossRef Google Scholar Sharkey SW, Lesser JR, Menon M et al (2008) Spectrum and significance of electrocardiographic patterns, troponin levels, and thrombolysis in myocardial infarction frame count in patients with stress (tako-tsubo) cardiomyopathy and comparison to those in patients with ST-elevation anterior wall myocardial infarction. Am J Cardiol 101:1723–1728 PubMed CrossRef Google Scholar Sharkey SW, Windenburg DC, Lesser JR et al (2010) Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol 55(4):333–341 PubMed CrossRef Google Scholar Smalling RW (2009) Time: the new gold standard for ST-segment elevation myocardial infarction care. J Am Coll Cardiol 54:2154–2156 PubMed CrossRef Google Scholar Smalling RW, Giesler GM, Julapalli VR et al (2007) Pre-hospital reduced-dose fibrinolysis coupled with urgent percutaneous coronary intervention reduces time to reperfusion and improves angiographic perfusion score compared with pre-hospital fibrinolysis alone or primary percutaneous coronary intervention: results of the PATCAR Pilot Trial. J Am Coll Cardiol 50:1612–1614 PubMed CrossRef Google Scholar Thiemann DR, Coresh J, Schulman SP et al (2000) Lack of benefit for IV thrombolysis in patients with MI who are older than 75 years. Circulation 101:2239 CAS PubMed Google Scholar Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF Task force for the redefinition of myocardial infarction (2007) Universal definition of myocardial infarction. Eur Heart J 28:2525–2538 PubMed CrossRef Google Scholar Van de Werf FJ (2006) Fine-tuning the selection of a reperfusion strategy. Circulation 114:2002–2003 PubMed CrossRef Google Scholar Vantrimpont P, Roleau JL, Chaun-Chaun W et al (1997) Additive beneficial effects of beta-blockers to angiotensin converting enzyme inhibitors in Survival and Ventricular Enlargement (SAVE) study. J Am Coll Cardiol 29:229 CAS PubMed CrossRef Google Scholar White HD, Chew DP (2008) Acute myocardial infarction. Lancet 372(9638):570–584 CrossRef CAS Google Scholar Wijeysundera HC, Vijayaraghavan R, Nallamothu BK et al (2007) Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials. J Am Coll Cardiol 49:422–430 PubMed CrossRef Google Scholar Wittstein IS, Thiemann DR, Lima JA et al (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352:539–548 CAS PubMed CrossRef Google Scholar Yamaji H, Iwsaki K, Kusachi S et al (2001) Prediction of acute left main coronary artery obstruction by 12- lead electrocardiography: ST-segment elevation in AVR with less ST-segment elevation in lead V1. J Am Coll Cardiol 38:1348 CAS PubMed CrossRef Google Scholar Suggested Reading American College of Cardiology/American Heart Association (2008) 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. J Am Coll Cardiol 51:210–247 CrossRef Google Scholar Benoit Arsenault J, Jamal Rana S, Erik Stroes SG et al (2010) Beyond low-density lipoprotein cholesterol: respective contributions of non–high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am Coll Cardiol 55:35–41 CrossRef CAS Google Scholar Bramlage P, Messer C, Bitterlich N et al (2010) The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction. Heart 96:604–609 CAS PubMed CrossRef Google Scholar David A (2010) Morrow cardiovascular risk prediction in patients with stable and unstable coronary heart disease. Circulation 121:2681–2691 CrossRef Google Scholar de Silva R, Fox KM (2009) The changing horizon of acute coronary syndrome. The Lancet 374:1125–1127 CrossRef Google Scholar Gibson CM, Pride YB, Hochberg CP et al for the TIMI Study Group (2009) Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome: PCI-PROVE IT: A PROVE IT–TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22) Substudy. J Am Coll Cardiol 54:2290–2295 CAS PubMed CrossRef Google Scholar Hasdai D (2010) Treating non–ST-segment elevation acute coronary syndromes: if you aren’t sure, at least do no harm. Circulation 121:843–845 PubMed CrossRef Google Scholar Heart Outcomes Prevention Evaluation Study Investigators (2000) Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 342:145–153. HOPE CrossRef Google Scholar Morrow DA, Scirica BM, Sabatine MS et al (2010) B-type natriuretic peptide and the effect of ranolazine in patients with non–ST-segment elevation acute coronary syndromes: observations from the MERLIN–TIMI 36 (Metabolic efficiency with ranolazine for less ischemia in Non-ST elevation acute coronary–thrombolysis in myocardial infarction 36) trial. J Am Coll Cardiol 55:1189–1196 CAS PubMed CrossRef Google Scholar Nawar EW, Niska RW, Xu J (2007) National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary. Advance data from vital and health statistics. No. 386, 2007. National Center for Health Statistics, Hyattsville Google Scholar Nykamp D, Titak JA (2010) Takotsubo cardiomyopathy, or Broken-Heart Syndrome. Ann Pharmacother 44(3):590–593 PubMed CrossRef Google Scholar Sanz J, Moreno PR, Valentin F (2010) The year in atherothrombosis. J Am Coll Cardiol 55:1487–1498 PubMed CrossRef Google Scholar Sune Pedersen H, Galatius S, Peter Hansen R (2009) Field triage reduces treatment delay and improves long-term clinical outcome in patients with acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 54:2296–2302 PubMed CrossRef Google Scholar Zeymer U, Margenet A, Haude M et al (2010) Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-Segment elevation myocardial infarction: results of the EVA-AMI Trial. J Am Coll Cardiol 56:463–469 CAS PubMed CrossRef Google Scholar Case Studies Acute Infarction Ramipril Efficacy (AIRE) Study Investigators (1993) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342:821. AIRE Google Scholar Ambrosioni E, Borghi C, Magnani B et al for the Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators (1995) The effect of the angiotensin-converting enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 332:80. SMILE CAS PubMed CrossRef Google Scholar Andersen HR, Nielsen TT, Rasmussen K et al (2003) A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349:733–742 PubMed CrossRef Google Scholar ASSENT-2 Investigators (1999) Assessment of the safety and efficacy of a new thrombolytic: single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomized trial. Lancet 354:716. ASSENT-2 CrossRef Google Scholar Assessment of the Safety and Efficacy of a New Thrombolytic Regimen Investigators (2001) Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial of acute myocardial infarction. Lancet 358:605–613. ASSENT-3 CrossRef Google Scholar β-Blocker Heart Attack Trial Research Group (1982) A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality Results BHAT. JAMA 247(12):1707–1714. BHAT CrossRef Google Scholar Cannon CP, Braunwald E, McCabe CH et al (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350:1495–1504 CAS PubMed CrossRef Google Scholar CAPRICORN Investigators (2001) Effect of carvedilol on outcome after MI in patients with left ventricular dysfunction; The CAPRICORN randomized trial. Lancet 357:1385–1390. CAPRICORN CrossRef Google Scholar Clopidogrel and Metoprolol in Myocardial Infarction Trial Collaborative Group (2005) Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo controlled trial. Lancet 366:1622–1632. COMMIT/CCS-2 CrossRef CAS Google Scholar GUSTO Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med GUSTO CrossRef Google Scholar L, C, et al (1995) A clinical trial of the inhibitor in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med CAS PubMed CrossRef Google Scholar et al for the Investigators (2009) Early versus invasive intervention in acute coronary syndromes. N Engl J Med CAS PubMed CrossRef Google Scholar Study Group (2000) The Metoprolol randomized intervention trial in Effects of metoprolol on total and in patients with heart failure. JAMA CrossRef Google Scholar Study Group in mortality and in patients acute myocardial infarction. N Engl J Med CrossRef Google Scholar Trial Investigators (2006) Effects of on mortality and in patients with acute ST-segment elevation myocardial infarction. The randomized trial. JAMA CrossRef Google Scholar M, JS, et al for the Randomized Survival Study (2001) Effect of carvedilol on in heart failure. N Engl J Med CAS PubMed CrossRef Google Scholar Peters RW, Muller JE, Goldstein S et al for the BHAT Study Group Propranolol and the morning increase in the frequency of sudden cardiac deaths (BHAT Study). Am J Cardiol BHAT CAS PubMed CrossRef Google Scholar MA, Braunwald E, et al for the Investigators Effect of on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement trial. N Engl J Med CAS PubMed CrossRef Google Scholar MA, EJ et al (2003) or both in myocardial infarction by heart left ventricular or N Engl J Med CAS PubMed CrossRef Google Scholar Cannon CP, McCabe CH et al for the PROVE 22 Investigators (2005) Early and of in patients with acute coronary syndromes: results from the PROVE 22 trial. J Am Coll Cardiol PROVE 22 CAS PubMed CrossRef Google Scholar Cannon CP, Morrow D et al for the or Atorvastatin Evaluation and Infection in Myocardial Infarction 22 22) Investigators (2005) and outcomes after statin therapy. N Engl J Med PROVE 22 CAS PubMed CrossRef Google Scholar E, et al for the Study Group (2008) to events in men and with elevated N Engl J Med CAS PubMed CrossRef Google Scholar International of Survival Collaborative Group (1988) trial of intravenous oral or among of suspected acute myocardial infarction: Lancet Google Scholar The Cardiac Study (1999) A randomized trial. Lancet CrossRef Google Scholar International Study of Survival Collaborative Group A randomised comparison of streptokinase and of aspirin heparin aspirin alone among of suspected acute myocardial infarction. Lancet Google Scholar
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction machine sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.
Scores du classifieur distillé par catégorie (deux têtes)
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,000 | 0,001 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,000 | 0,000 |
| Bibliométrie | 0,001 | 0,001 |
| Études des sciences et des technologies | 0,000 | 0,000 |
| Communication savante | 0,000 | 0,000 |
| Science ouverte | 0,000 | 0,001 |
| Intégrité de la recherche | 0,001 | 0,001 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,102 | 0,043 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».